For example, p57 is targeted by miR221/222 in gastric, lung and hepatocellular cancers, promoting cell proliferation and tumor growth (Fornari et al., 2008; Kim et al., 2009; Wang et al., 2013). Here, CDKN1C is linked to hepatocellular carcinoma.